|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Institute of Pharmacology and Therapeutics, Faculty of Medicine, Porto, Portugal
2 Department of Pediatrics, Georgetown University Medical Center, Washington, DC, USA
* To whom correspondence should be addressed. E-mail: psoaresdasilva{at}netcabo.pt.
Dopamine-induced inhibition of Na+-K+-ATPase has been suggested to play a role in the regulation of Na+ absorption at the intestinal level and these effects were mediated by dopamine D1-like receptors. The aim of this work was to evaluate the effect of the activation of the D1-like receptors on the activity of the Na+/H+ exchanger (NHE) in the rat intestinal epithelial cell line IEC-6. The presence of D1 receptors was confirmed by immunoblotting. The dopamine D1-like receptor agonist SKF 38393 produced a concentration-dependent inhibition of NHE activity and stimulation of adenylyl cyclase (AC), this being antagonized by the D1 selective antagonist SKF 83566. Effects of SKF 38393 on NHE and AC activities were maximal at 5 min of exposure to the agonist and rapidly diminished with no effect at 25 min. Exposure of cells for 25 min to dibutyryl-cAMP (0.5 mM) or to the AC activator forskolin (3 µM) effectively inhibited NHE activity. Pretreatment of cells with heparin (1 µM), a non-selective G protein coupled-receptor kinase (GRK) inhibitor, prevented the loss of effects on NHE activity after 25 min exposure to SKF 38393. The presence of GRK 4, GRK 6A and GRK 6B was confirmed by immunoblotting. Overnight treatment with the anti-GRK 4-6 antibody complexed with Lipofectin was also effective in preventing loss of the effects of SKF 38393 on NHE and AC activities. It is concluded that dopamine D1 receptors in IEC-6 rapidly desensitize to D1-like agonist stimulation and GRK 4 and 6 appear to be involved in agonist-mediated responsiveness and desensitization.
This article has been cited by other articles:
![]() |
C. Zeng, V. A. M. Villar, G. M. Eisner, S. M. Williams, R. A. Felder, and P. A. Jose G Protein-Coupled Receptor Kinase 4: Role in Blood Pressure Regulation Hypertension, June 1, 2008; 51(6): 1449 - 1455. [Full Text] [PDF] |
||||
![]() |
H. Sanada, J. Yatabe, S. Midorikawa, T. Katoh, S. Hashimoto, T. Watanabe, J. Xu, Y. Luo, X. Wang, C. Zeng, et al. Amelioration of Genetic Hypertension by Suppression of Renal G Protein-Coupled Receptor Kinase Type 4 Expression Hypertension, June 1, 2006; 47(6): 1131 - 1139. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |